Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Mulleman

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Therapie|August 8, 2014
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Therapie|July 10, 2016
[Not Available]Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Frontiers in Immunology|April 11, 2024
Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cellsLucille Lamendour, Mäelle Gilotin, Nora Deluce-Kakwata Nkor, et al.
Joint Bone Spine|December 26, 2021
Spine immobilization and neurological outcome in vertebral osteomyelitis SPONDIMMO, a prospective multicentric cohortAdrien Le Pluart, Guillaume Coiffier, Christelle Darrieutort-Lafitte, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 26, 2011
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective studyThierry Conrozier, Jean-Charles Balblanc, Pascal Richette, et al.
RMD Open|March 2, 2023
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi studyCéleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, et al.
Lancet (London, England)|December 4, 2014
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trialLouis Bernard, Aurélien Dinh, Idir Ghout, et al.
Arthritis Research & Therapy|September 30, 2020
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre studyEric Toussirot, Hubert Marotte, Denis Mulleman, et al.
Joint Bone Spine|August 8, 2020
2020 French recommendations on the management of septic arthritis in an adult native jointMarion Couderc, Géraldine Bart, Guillaume Coiffier, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritisDavid Moulin, Marie Millard, Mahdia Taïeb, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Therapie|August 8, 2014
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Therapie|July 10, 2016
[Not Available]Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Frontiers in Immunology|April 11, 2024
Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cellsLucille Lamendour, Mäelle Gilotin, Nora Deluce-Kakwata Nkor, et al.
Joint Bone Spine|December 26, 2021
Spine immobilization and neurological outcome in vertebral osteomyelitis SPONDIMMO, a prospective multicentric cohortAdrien Le Pluart, Guillaume Coiffier, Christelle Darrieutort-Lafitte, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 26, 2011
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective studyThierry Conrozier, Jean-Charles Balblanc, Pascal Richette, et al.
RMD Open|March 2, 2023
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi studyCéleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, et al.
Lancet (London, England)|December 4, 2014
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trialLouis Bernard, Aurélien Dinh, Idir Ghout, et al.
Arthritis Research & Therapy|September 30, 2020
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre studyEric Toussirot, Hubert Marotte, Denis Mulleman, et al.
Joint Bone Spine|August 8, 2020
2020 French recommendations on the management of septic arthritis in an adult native jointMarion Couderc, Géraldine Bart, Guillaume Coiffier, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritisDavid Moulin, Marie Millard, Mahdia Taïeb, et al.
Pageof 10